ardisiacrispin b has been researched along with epirubicin in 1 studies
| Studies (ardisiacrispin b) | Trials (ardisiacrispin b) | Recent Studies (post-2010) (ardisiacrispin b) | Studies (epirubicin) | Trials (epirubicin) | Recent Studies (post-2010) (epirubicin) |
|---|---|---|---|---|---|
| 8 | 0 | 2 | 5,453 | 1,838 | 1,570 |
| Protein | Taxonomy | ardisiacrispin b (IC50) | epirubicin (IC50) |
|---|---|---|---|
| Genome polyprotein | 0.75 | ||
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | 5.181 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, L; Hui, LP; Koike, K; Li, Q; Li, W; Zhao, CY | 1 |
1 other study(ies) available for ardisiacrispin b and epirubicin
| Article | Year |
|---|---|
13,28-Epoxy triterpenoid saponins from Ardisia japonica selectively inhibit proliferation of liver cancer cells without affecting normal liver cells.
Topics: Antineoplastic Agents, Phytogenic; Ardisia; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Hep G2 Cells; Humans; Liver Neoplasms; Molecular Conformation; Saponins; Structure-Activity Relationship; Triterpenes | 2012 |